Katalog der Deutschen Nationalbibliothek

Go to:

Catalogue (Beta)

Knowledge Web

Person
Person

Person

Patrick Metzger

Biologe

Name

Patrick Metzger

Time

2020- (Wirkungsdaten)

Place

Emmendingen (Geburtsort)
Deutschland

Gender

männlich

Academic degree

Dr. rer. nat.

Profession

Biologe (characteristic profession)

Further information

Dissertation 2020, Universität Freiburg, Fakultät für Biologie

Source

FreiDok plus

Record type

Person

GND-Identifier

120822770X

Record ID

120822770X

Involved in

show all

Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors

Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: genetic evidence of driver function and implications for diagnostic workup

Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma

Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors

Das Verbundprojekt "Personalisierte Medizin für die Onkologie" (PM4Onco) als Teil der Medizininformatik-Initiative (MII) = The collaborative project "Personalized medicine for oncology" (PM4Onco) as part of the Medical Informatics Initiative (MII)

Identifications of similarity metrics for patients with cancer: protocol for a scoping review

PM4Onco: personalisierte Medizin für die Onkologie : : effektive Datennutzung für molekulare Tumorboards = PM4Onco: personalized medicine for oncology : effective use of data for molecular tumor boards

Sondersituation der Daten in der Onkologie = Data complexity in oncology

Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients

Extending cBioPortal for therapy recommendation documentation in molecular tumor boards: development and usability study

MIRACUM-Pipe : : an adaptable pipeline for next-generation <br>sequencing analysis, reporting, and visualization for clinical decision making

Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients

Profile of the multicenter cohort of the German Cancer Consortium’s Clinical Communication Platform

PI3K/AKT signaling allows for MAPK/ERK pathway independency mediating dedifferentiation-driven treatment resistance in melanoma

Krüppel-like factor 7 influences translation and pathways involved in ribosomal biogenesis in breast cancer

ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma

Krüppel-like factor 7 influences translation and pathways involved in ribosomal biogenesis in breast cancer

Krüppel-like factor 7 influences translation and pathways involved in ribosomal biogenesis in breast cancer

PI3K/AKT signaling allows for MAPK/ERK pathway independency mediating dedifferentiation-driven treatment resistance in melanoma

Progressive liver, kidney, and heart degeneration in children and adults affected by TULP3 mutations

Dynamic transcriptome analysis reveals signatures of paradoxical effect of vemurafenib on human dermal fibroblasts

Combination of Lenvatinib and Pembrolizumab is an effective treatment option for anaplastic and poorly differentiated thyroid carcinoma

Dynamic transcriptome analysis reveals signatures of paradoxical effect of vemurafenib on human dermal fibroblasts

Transitioning the molecular tumor board from proof of concept to clinical routine: a german single-center analysis

Annotation of human exome gene variants with consensus pathogenicity

Cathepsin D deficiency in mammary epithelium transiently stalls breast cancer by interference with mTORC1 signaling

HIF-1[alpha] and HIF-2[alpha] differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice

Requirements analysis and specification for a molecular tumor board platform based on cBioPortal

Requirements Analysis and Specification for a Molecular Tumor Board Platform Based on cBioPortal

Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency

Systems medicine in the scope of multi omics analyses

Systems medicine in the scope of multi omics analyses

Personalized clinical decision making through implementation of a molecular tumor board: a German single-center experience

Personalized clinical decision making through implementation of a molecular tumor board: a German single-center experience
Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

DNB portal